Search

Purpose: Few data have been published on the efficacy of linezolid in enterococcal urinary tract infection (e-UTI). The aims of this study were to describe the characteristics of patients with enterococci UTI treated with linezolid, and to evaluate the efficacy and the tolerance of linezolid treatment., Methods: An observational multicentre retrospective study was conducted in 5 hospitals in France. Patients were included if they met the following criteria: ≥18 years, clinical and microbiological criteria for enterococcal UTI and linezolid treatment > 48 h. Primary outcome was clinical failure., Results: Eighty-one patients were included between January 2015 and December 2021. The median age was 73.0 [64; 83] years and 47 (58%) were men. The median Charlson comorbidity index was 3.00 [2; 6]. E. faecium was reported in 65 (80%) cases and E. faecalis in 26 cases (32%). Polymicrobial infections occurred in 41 (51%) cases. No enterococci was resistant to vancomycin. Before linezolid prescription an empiric antimicrobial treatment was started in 48 (59%) cases and was effective against enterococci in 19/48 (39.5%) patients for a median of 3.5 days [2.0; 4.0]. The median duration of linezolid antibiotic treatment was 13 days [10; 14]. Three adverse events were reported, none were serious but one led to discontinuation of treatment. Treatment failure was reported in 2 cases (2.5%)., Conclusion: This study provides evidence for efficacy and safety of linezolid in enterococcal UTI., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)

Introduction: 18 F-FDG-PET/CT is recommended to improve the diagnosis of prosthetic valve infective endocarditis (PVIE) and is a major criterion in the ESC-2015 classification. However, there is little evidence for its usefulness in the follow-up of medically treated PVIE patients., Methods: A monocentric retrospective analysis of patients hospitalized for PVIE between January 2013 and December 2019 who were not treated with surgery and who had at least two 18 F-FDG-PET/CT examinations during their medical management., Results: Among 170 patients with PVIE, 117 were treated with antibiotic therapy but no surgery. Of these, 36 (31%) had at least two 18 F-FDG-PET/CT examinations. At initial imaging, 28 patients had heterogeneous FDG uptake on their prosthetic valve and eight on their associated aortic graft. Hypermetabolism of spleen and bone marrow (HSBM) was observed in 18 and 19 patients, respectively. At the first follow-up 18 F-FDG-PET/CT, 21 (58%) patients still had heterogeneous uptake, indicating persistent active endocarditis. HSBM was still present at the last follow-up imaging in four of the six patients with recurrent PVIE., Conclusion: 18 F-FDG-PET/CT monitoring of medically treated patients with PVIE provides valuable additional information and prospective multicentric study should be conducted to assess its usefulness., (© 2023. The Author(s) under exclusive licence to American Society of Nuclear Cardiology.)

Background: This study aims to determine whether the suppression of myocardial FDG uptake and detection of infectious endocarditis (IE) may be enhanced when FDG-PET is repeated on the next day while maintaining patients on a ketogenic diet in the interim., Methods: Seventeen patients with definite IE underwent FDG-PET investigations both after a conventional metabolic preparation (> 12-hour fast after a low-carbohydrate evening meal) and a subsequent 12-hour extension of the low-carbohydrate diet followed by an additional > 12-hour fast., Results: Plasma biomarkers showed increased ketogenic metabolism between the two FDG-PET scans. A myocardial FDG uptake persisted on the 1st PET in 9 patients (53%) for whom myocardial FDG uptake decreased significantly on the 2nd PET (SUVmax: 6.05 ± 3.25 vs 4.32 ± 3.47, P = 0.021), resulting in an enhancement in the diagnostic confidence of IE in 6 cases. These enhancements were not documented in the 8 patients exhibiting a total suppression of myocardial FDG uptake on the 1st PET., Conclusions: Better suppression of myocardial uptake and enhanced detection of IE may be achieved when an FDG-PET, showing an incomplete suppression of the myocardial FDG uptake, is repeated as soon as the next day, while maintaining patients on a ketogenic diet in the interim., (© 2022. The Author(s) under exclusive licence to American Society of Nuclear Cardiology.)

Purpose: To assess the impact of peritoneal endometriosis on oocyte and embryo quality in a mouse model., Methods: Peritoneal endometriosis was surgically induced in 33 B6CBA/F1 female mice (endometriosis group, N = 17) and sham-operated were used as control (sham group, N = 16). Mice were superovulated 4 weeks after surgery and mated or not, to collect E0.5-embryos or MII-oocytes. Evaluation of oocyte and zygote quality was done by immunofluorescence under spinning disk confocal microscopy., Results: Endometriosis-like lesions were observed in all mice of endometriosis group. In both groups, a similar mean number of MII oocytes per mouse was observed in non-mated mice (30.2 vs 32.6), with a lower proportion of normal oocytes in the endometriosis group (61 vs 83 %, p < 0.0001). Abnormalities were incomplete extrusion or division of the first polar body and spindle abnormalities. The mean number of zygotes per mouse was lower in the endometriosis group (21 vs 35.5, p = 0.02) without difference in embryo quality., Conclusions: Our results support that induced peritoneal endometriosis in a mouse model is associated with a decrease in oocyte quality and embryo number. This experimental model allows further studies to understand mechanisms of endometriosis-associated infertility.

In order to contribute to the inventory of genomic areas involved in maize cell wall lignification and degradability, QTL analyses were investigated in a RIL progeny between an old Minnesota13 dent line (WM13) and a modern Iodent line (RIo). Significant variation for agronomic- and cell wall-related traits was observed for the RIL per se (plants without ears) and topcross (whole plants) experiments after crossing with both old (Ia153) and modern tester (RFl) lines. Three QTLs for stover (plant without ear) yield were observed in per se experiments, with alleles increasing yield originating from RIo in two genomic locations with the highest effects. However, no QTL for whole plant yield was detected in topcross experiments, despite the fact that two QTLs for starch content were shown with increasing alleles originating from the modern RIo line. Fifteen lignin QTLs were shown, including a QTL for Klason lignins in per se experiments, located in bin 2.04, which explained 43 % of the observed genetic variation. Thirteen QTLs for p-hydroxycinnamic acid contents and nine QTLs related to the monomeric composition of lignin were shown in per se experiments, with syringaldehyde and diferulate QTLs explaining nearly 25 % of trait variations. Nine and seven QTLs for cell wall digestibility were mapped in per se and topcross experiments, respectively. Five of the per se QTLs explained more than 15 % of the variation, up to nearly 25 %. QTL positions in bins 2.06, 5.04, 5.08 and 8.02 for ADL/NDF, IVNDFD, lignin structure and/or p-hydroxycinnamic acid contents have not been previously shown and were thus first identified in the RIo × WM13 progeny. Based on QTL colocalizations, differences in cell wall degradability between RIo and WM13 were less often related to acid detergent lignin (ADL) content than in previous RIL investigations. QTL colocalizations then highlighted the probable importance of ferulate cross linkages in variation for cell wall digestibility. No colocalizations of QTL for cell wall phenolic-related traits were shown with genes involved in monolignol biosynthesis or polymerization. In contrast, colocalizations were most often shown with MYB and NAC transcription factors, including orthologs of master genes involved in Arabidopsis secondary wall assembly. QTL colocalizations also strengthened the probable involvement of members of the CoA-dependent acyltransferase PF02458 family in the feruloylation of arabinoxylan chains.